Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global xerostomia treatment market is expected to grow at a CAGR of 3.5 % in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is expected to lead the market for xerostomia treatment, followed by Europe. The major factors governing the market dominance include prominent growth in the number of xerostomia cases as well as other diseases that lead to dry-mouths, such as Sjogren's syndrome, rheumatoid arthritis, and HIV. The large number is also due to the significant geriatric population in these areas. Awareness camps are frequently conducted by various organizations across the US and Canada by the Sjogren's Syndrome Foundation about the disease. Ease of access and availability of healthcare facilities, and robust medical infrastructure with conducive compensation scenarios are some of the important factors, which are helping the market grow in North America. As the Asia-Pacific region is expected to grow at a fast rate during the forecast period, and as healthcare expenditure and awareness about various health conditions improve, the market for xerostomia therapies is expected to grow in these regions. Ailments such as Parkinson’s disease, cancer, diabetes mellitus, are a few of the dry mouth associated diseases. As the awareness of these diseases increases, the market for xerostomia is, in turn, expected to rise over the forecast period.
Xerostomia, also known as the dry-mouth condition, is a state of lack of saliva production in the mouth. This might also be a consequence of the change in the quality of saliva produced. Normally, it arises due to many different reasons, such as side effects of medicine, dehydration, mouth bleeding, adverse effects of radiation especially due to radiation in surgery, cigarette smoking. Xerostomia is seen as a by-product of other health conditions and is not considered a disease. This condition is majorly observed in the elderly population. Chemotherapy, Sjogren’s Syndrome and HIV are also some of the dry mouth associated diseases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on product, the industry is segmented into:
By type, the industry is bifurcated into:
On the basis of distribution channels, the industry is segregated into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing consumption and dependence on medication is the major driver for the rise of xerostomia treatment industry. A growing number of cases of Sjogren's syndrome as well as diagnosis of it is also a major driver of this market. Moreover, as the geriatric population is increasing across the globe, coupled with increasing cases of chronic and lifestyle related diseases, the market is expected to enhance during the forecast period. There has been a rising awareness towards the diagnosis of xerostomia in recent years is aiding the market growth. This is expected to boost the market growth in the forecast period as well. Further, the increase in the cases of diseases such as cancer, HIV, and Sjogren’s syndrome drives the demand for radiation and chemotherapy. Xerostomia is a side-effect of these treatments. However, lack of health awareness towards xerostomia in developing countries is expected to decelerate the growth of this market.
The report gives a detailed analysis of the following key players in the global xerostomia treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Type |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global xerostomia treatment market is projected to grow at a CAGR of 3.5% between 2024 and 2032.
The major drivers of the market include the rising geriatric population, increasing cases of chronic and lifestyle related diseases, rising awareness towards the diagnosis of xerostomia, increase in the cases of diseases such as cancer, HIV, ease of access and availability of healthcare facilities, and robust medical infrastructure.
The increasing consumption and dependence on medication and a growing number of cases of Sjogren's syndrome as well as its diagnosis are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The products include artificial saliva, salivary stimulants, saliva substitutes, drugs, and salivary pens, among others.
OTC and prescription are the types of xerostomia treatments.
The xerostomia treatment market can be broadly categorised based on its distribution channels into hospital pharmacies, retail pharmacies, and online, among others.
The major players in the industry are 3M Co., GlaxoSmithKline plc, Saliwell Ltd, Sun Pharmaceutical Industries Ltd, and Cumberland Pharmaceuticals Inc., among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share